These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9369910)

  • 21. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy.
    Onimaru R; Fujino M; Yamazaki K; Onodera Y; Taguchi H; Katoh N; Hommura F; Oizumi S; Nishimura M; Shirato H
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):374-81. PubMed ID: 18029106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standard thoracic radiotherapy with or without concurrent daily low-dose carboplatin in elderly patients with locally advanced non-small cell lung cancer: a phase III trial of the Japan Clinical Oncology Group (JCOG9812).
    Atagi S; Kawahara M; Tamura T; Noda K; Watanabe K; Yokoyama A; Sugiura T; Senba H; Ishikura S; Ikeda H; Ishizuka N; Saijo N;
    Jpn J Clin Oncol; 2005 Apr; 35(4):195-201. PubMed ID: 15845568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recent advances in radiation therapy for non-small cell lung cancer].
    Morita K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():103-6. PubMed ID: 9216195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
    Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
    Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The recent progress in chemoradiotherapy of lung cancer].
    Ogawara M; Kawahara M; Furuse K
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2058-64. PubMed ID: 9388514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium.
    Marks LB; Garst J; Socinski MA; Sibley G; Blackstock AW; Herndon JE; Zhou S; Shafman T; Tisch A; Clough R; Yu X; Turrisi A; Anscher M; Crawford J; Rosenman J;
    J Clin Oncol; 2004 Nov; 22(21):4329-40. PubMed ID: 15514374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent end-phase boost high-dose radiation therapy for non-small-cell lung cancer with or without cisplatin chemotherapy.
    Graham PH; Clark C; Abell F; Browne L; Capp A; Clingan P; De Sousa P; Fox C; Links M
    Australas Radiol; 2006 Aug; 50(4):342-8. PubMed ID: 16884421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Radiation therapy for lung cancer].
    Shibuya K; Hiraoka M
    Gan To Kagaku Ryoho; 2007 Apr; 34(4):544-9. PubMed ID: 17431339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal thoracic radiation therapy in unresectable stage IIIA/B nonsmall cell lung carcinoma: a modified Phase I trial.
    Socinski MA; Rosenman JG; Schell MJ; Halle J; Russo S; Rivera MP; Clark J; Limentani S; Fraser R; Mitchell W; Detterbeck FC
    Cancer; 2000 Aug; 89(3):534-42. PubMed ID: 10931452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomised clinical trial of radiotherapy plus cisplatin versus radiotherapy alone in stage III non-small cell lung cancer.
    Cakir S; Egehan I
    Lung Cancer; 2004 Mar; 43(3):309-16. PubMed ID: 15165089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Radiation treatment of lung cancer].
    Hayakawa K
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1211-4. PubMed ID: 17847583
    [No Abstract]   [Full Text] [Related]  

  • 32. Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial.
    van Baardwijk A; Bosmans G; Bentzen SM; Boersma L; Dekker A; Wanders R; Wouters BG; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1103-10. PubMed ID: 18258382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study.
    Bonner JA; McGinnis WL; Stella PJ; Marschke RF; Sloan JA; Shaw EG; Mailliard JA; Creagan ET; Ahuja RK; Johnson PA
    Cancer; 1998 Mar; 82(6):1037-48. PubMed ID: 9506347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localized small-cell lung cancer: which type of thoracic radiotherapy and which time schedule.
    Stuschke M; Pöttgen C
    Lung Cancer; 2004 Aug; 45 Suppl 2():S133-7. PubMed ID: 15552793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interruptions of high-dose radiation therapy decrease the long-term survival of favorable patients with unresectable non-small-cell carcinoma of the lung. Analysis of 1244 cases from radio-oncology (RTOG) studies. Radiation Therapy Oncology Group].
    Herrmann T
    Strahlenther Onkol; 1994 Sep; 170(9):551-2. PubMed ID: 7940128
    [No Abstract]   [Full Text] [Related]  

  • 37. Continuous hyperfractionated accelerated radiotherapy (CHART) and non-conventionally fractionated radiotherapy in the treatment of non-small cell lung cancer: a review and consideration of future directions.
    Hatton MQ; Martin JE
    Clin Oncol (R Coll Radiol); 2010 Jun; 22(5):356-64. PubMed ID: 20399629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3-D conformal radiation therapy for non-small cell lung carcinoma. Clinical experience at the Memorial Sloan-Kettering Cancer Center.
    Leibel SA; Armstrong JG; Kutcher GJ; Zelefsky MJ; Burman CM; Mohan R; Ling CC; Fuks Z
    Front Radiat Ther Oncol; 1996; 29():199-206. PubMed ID: 8742900
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiac toxicity and radiation dose to the heart in definitive treated non-small cell lung cancer.
    Schytte T; Hansen O; Stolberg-Rohr T; Brink C
    Acta Oncol; 2010 Oct; 49(7):1058-60. PubMed ID: 20831496
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of radiation therapy in the management of non-small cell lung cancer.
    Machtay M; Friedberg JS
    Semin Thorac Cardiovasc Surg; 1997 Jan; 9(1):80-9. PubMed ID: 9109228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.